GREK

GREK remains in a Stage 2 advancing regime with a bullish medium-term bias reinforced by higher highs and higher lows. Price is holding and pulling back into the rising 9- and 20-day EMAs near its 52-week high, offering a favorable entry. Under the Stable strategy, patient engagement around these dynamic supports into continued strength is warranted.

• ↑YTD gain of 18.9%; 52-week range $60.53–$83.33 shows recovery
• ↑MACD and A.I.dvisor momentum indicators turned positive on July 27
• ↓Financials concentration (~49%) heightens vulnerability to sector downturns